SANA Earnings & Financial Statements
Sana Biotechnology, Inc.
$2.33
-$0.08(-3.32%)
27
Overall
45
Value
18
Tech
18
Quality
Market Cap
$697.51M
Volume
2.76M
52W Range
$2.61 - $6.55
Target Price
$9.38
SANA earnings and financial statements: Sana Biotechnology, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
SANA Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating income | -$250.32M | -$272.72M | -$293.14M | -$272.56M | -$356.91M |
| EBITDA | -$238.75M | -$267.55M | -$279.93M | -$241.75M | -$222.24M |
| Net income | -$244.17M | -$266.76M | -$283.25M | -$269.48M | -$355.93M |
| EPS (diluted) | $-0.96 | $-1.16 | $-1.46 | $-1.43 | $-2.14 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $416.89M | $501.02M | $565.30M | $822.72M | $1.13B |
| Total liabilities | $256.01M | $250.52M | $277.79M | $323.40M | $400.90M |
| Shareholders’ equity | $160.88M | $250.50M | $287.51M | $499.31M | $728.50M |
| Cash and equivalents | $71.87M | $127.57M | $133.52M | $176.76M | $253.03M |
| Long-term debt | $63.92M | $81.66M | $90.90M | $95.86M | $101.78M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$143.83M | -$223.15M | -$253.58M | -$290.05M | -$251.05M |
| Capital expenditure | $494.0K | -$33.43M | -$20.03M | -$20.88M | -$29.86M |
| Free cash flow | -$144.77M | -$256.58M | -$273.61M | -$310.93M | -$280.92M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SANA | $2.33 | -3.3% | 2.76M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Sana Biotechnology, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW